학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 237건 | 목록 1~20
Academic Journal
Müller DC; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; Department of Urology, University Hospital Basel, University of Basel, Basel, Switzerland.; Murtha AJ; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; Bacon JVW; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; Stephenson M; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; Wells C; Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada.; Vasquez-Rios C; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; Rostin K; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; Rebane L; Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada.; Schönlau E; Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada.; Nikkola J; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; Alimohamed N; Department of Medical Oncology, Arthur J.E. Child Comprehensive Cancer Centre, Calgary, AB, Canada.; Basappa NS; Department of Medical Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada.; Finch D; Department of Medical Oncology, BC Cancer, Kelowna, BC, Canada.; Ko JJ; Department of Medical Oncology, BC Cancer, Abbotsford, BC, Canada.; Lavoie JM; Department of Medical Oncology, BC Cancer, Victoria, BC, Canada.; Nappi L; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada.; Noonan K; Department of Medical Oncology, BC Cancer, Surrey, BC, Canada.; Ong M; The Ottawa Hospital-Research Institute, Ottawa, ON, Canada.; Ozgun G; Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada.; Parimi S; Department of Medical Oncology, BC Cancer, Victoria, BC, Canada.; Soleimani M; Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada.; Sridhar SS; Princess Margaret Cancer Centre, Toronto, ON, Canada.; Toren P; CHU de Québec-Université Laval, Laval University, Quebec City, QC, Canada.; Winquist E; Verspeeten Family Cancer Centre at London Health Sciences Centre, London, ON, Canada.; Bernales CQ; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; Koudjanian M; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; Atwal J; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; Fung E; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; Khan L; Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada.; Eigl B; Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada.; Othman D; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada.; Bismar TA; Departments of Pathology and Laboratory Medicine, Oncology, Biochemistry and Molecular Biology, University of Calgary, Cumming School of Medicine, Calgary, AB, Canada.; Wang G; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, BC Cancer, Vancouver, BC, Canada.; Merza R; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.; Papadakis AI; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.; Spatz A; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.; Kollmannsberger C; Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada.; Maurice-Dror C; Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada.; Annala M; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland.; Chi KN; Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada.; Vandekerkhove G; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. gvandekerkhove@prostatecentre.com.; Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada. gvandekerkhove@prostatecentre.com.; Wyatt AW; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. alexander.wyatt@ubc.ca.; Department of Basic and Translational Research, BC Cancer Research Centre, Vancouver, BC, Canada. alexander.wyatt@ubc.ca.; Eigl BJ; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. bernie.eigl@bccancer.bc.ca.; Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada. bernie.eigl@bccancer.bc.ca.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Hanna L; Department of Medical Oncology, Verspeeten Family Cancer Centre, London Health Sciences Centre, London, ON, Canada.; O'Dwyer R; Division of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada, Mater Misericordiae University Hospital and Cavan General Hospital, Dublin, Ireland.; Hamilou Z; Department of Medicine, Hematology-Oncology Division, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada.; Noonan K; Department of Medical Oncology, BC Cancer, Surrey, BC, Canada.; Doucette S; Impact Medicom Inc., Toronto, ON, Canada.; Sridhar SS; Division of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada, Mater Misericordiae University Hospital and Cavan General Hospital, Dublin, Ireland.
Publisher: Canadian Urological Association Country of Publication: Canada NLM ID: 101312644 Publication Model: Print Cited Medium: Print ISSN: 1911-6470 (Print) Linking ISSN: 19116470 NLM ISO Abbreviation: Can Urol Assoc J Subsets: PubMed not MEDLINE
Academic Journal
Alimohamed NS; Division of Medical Oncology, Arthur J.E. Child Comprehensive Cancer Centre, University of Calgary, Calgary, AB, Canada.; Gotto G; Departments of Surgery and Oncology, University of Calgary, Calgary, AB, Canada.; Kulkarni GS; Divisions of Urology and Surgical Oncology, Department of Surgery, University Health Network, University of Toronto, Toronto, ON, Canada.; Black PC; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; Kassouf W; Department of Surgery (Urology), McGill University Health Center, Montreal, QC, Canada.; Sridhar SS; Division of Medical Oncology, University of Toronto, Princess Margaret Cancer Centre, Toronto, ON, Canada.; Kokorovic A; Department of Urology, Dalhousie University, Halifax, NS, Canada.; Eigl BJ; BC Cancer, Vancouver, BC, Canada.; Blais N; Division of Medical Oncology and Hematology, Department of Medicine, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.; Lalani AA; Department of Oncology, Juravinski Cancer Centre, McMaster University, Hamilton, ON, Canada.; Cheung WY; Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.; Oncology Outcomes, Calgary, AB, Canada.; Stephen M; Oncology Outcomes, Calgary, AB, Canada.; Department of Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada.; Osborne BJW; Johnson & Johnson Innovative Medicine, Toronto, ON, Canada.; Wallis CJD; Urologic Oncology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada.
Publisher: Canadian Urological Association Country of Publication: Canada NLM ID: 101312644 Publication Model: Print Cited Medium: Print ISSN: 1911-6470 (Print) Linking ISSN: 19116470 NLM ISO Abbreviation: Can Urol Assoc J Subsets: PubMed not MEDLINE
Academic Journal
Al-Ezzi EM; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Abdeljalil O; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Lajkosz K; Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Gramolini SS; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Alqaisi H; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Peng J; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Odwyer R; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Alghamdi M; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Almuthri S; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Kumar V; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Jiang DM; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Fallah-Rad N; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Fleshner N; Division of urology, department of surgery, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Sridhar SS; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. Electronic address: srikala.sridhar@uhn.ca.
Publisher: Elsevier Country of Publication: United States NLM ID: 9805460 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2496 (Electronic) Linking ISSN: 10781439 NLM ISO Abbreviation: Urol Oncol Subsets: MEDLINE
Academic Journal
Bellmunt J; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: joaquim_bellmunt@dfci.harvard.edu.; Powles T; Centre for Experimental Cancer Medicine, Barts Cancer Institute, Queen Mary University of London, St Bartholomew's Hospital, London, UK.; Park SH; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.; Voog E; Centre Jean Bernard Clinique Victor Hugo, Le Mans, France.; Valderrama BP; Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain.; Gurney H; Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Australia.; Ullén A; Department of Pelvic Cancer, Genitourinary Oncology Unit, Karolinska University Hospital, Solna, Sweden.; Loriot Y; Gustave Roussy, INSERMU981, Université Paris-Saclay, Villejuif, France.; Sridhar SS; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Tsuchiya N; Department of Urology, Yamagata University Faculty of Medicine, Yamagata, Japan.; Sternberg CN; Englander Institute for Precision Medicine, Meyer Cancer Center, New York, NY, USA.; Aragon-Ching JB; Inova Schar Cancer Institute, Fairfax, VA, USA.; Petrylak DP; Yale Cancer Center, New Haven, CT, USA.; Climent Duran MA; Instituto Valenciano de Oncología, Valencia, Spain.; Tyroller K; EMD Serono Research & Development Institute, Inc. (an affiliate of Merck KGaA), Billerica, MA, USA.; Hoffman J; EMD Serono Research & Development Institute, Inc. (an affiliate of Merck KGaA), Billerica, MA, USA.; Jacob N; Merck Healthcare KGaA, Darmstadt, Germany.; Grivas P; Fred Hutchinson Cancer Center, University of Washington, Seattle, WA, USA.; Gupta S; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE
Report
Gupta S; Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA. guptas5@ccf.org.; Moon HH; Kaiser Permanente Riverside Medical Center, Riverside, CA, USA.; Sridhar SS; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE
Academic Journal
Powles TB; Barts Cancer Centre, Queen Mary University of London, London, UK.; Grande E; Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain.; Alimohamed N; Department of Medicine, University of Calgary, Calgary, Alberta, Canada.; Oliveira N; Mater Hospital Brisbane, Mater Misericordiae, and the School of Clinical Medicine, Mater Clinical Unit, University of Queensland, Brisbane, Australia.; Sridhar SS; Division of Medical Oncology, University of Toronto, Princess Margaret Cancer Center, Toronto, ON, Canada.; Drakaki A; Division of Hematology/Oncology, David Geffen School of Medicine, Los Angeles, CA, USA.; Kanesvaran R; Division of Medical Oncology, National Cancer Center Singapore, Singapore, Singapore.; Loriot Y; Department of Cancer Medicine, Institut de Cancérologie Gustave Roussy, Villejuif, France.; Necchi A; Department of Medical Oncology, Vita-Salute San Raffaele University IRCCS San Raffaele Hospital and Scientific Institute, Milan, Italy.; Franco S; Merck & Co, Inc, Rahway, NJ, USA.; Jiang D; Pfizer Oncology, Pfizer Inc, South San Francisco, CA, USA.; Apolinario K; Pfizer Oncology, Pfizer Inc, South San Francisco, CA, USA.; Zhang W; Pfizer Oncology, Pfizer Inc, South San Francisco, CA, USA.; Galsky MD; Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Sridhar, Srikala S
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어